Brooks Laboratories Ltd - 533543 - Submission Of Additional Details Sought For Corporate Announcement Submitted Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Brooks Laboratories approved the sale of 51,220 equity shares in Brooks Steriscience Limited for Rs.106.33 crore. The company will use the proceeds for its growth strategy, including operations expansion and capacity enhancement.
Jun 20 2026 15:06:27
Brooks Laboratories Ltd - 533543 - Partial Sale Of Equity Shares Held In Brooks Steriscience Limited
Brooks Laboratories sold 51,220 equity shares (16.33% stake) of Brooks Steriscience Limited for Rs.106.33 crore. This partial monetization aims to fund the company's growth strategy, operational expansion, and capacity enhancement.
Jun 19 2026 21:32:51
Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Change in Management
Brooks Laboratories appointed Mr. Prashant Rathi as Chief Executive Officer, effective June 1, 2026. He will continue to serve as the Chief Financial Officer, leveraging his 13+ years of experience and 5+ years with the company.
May 29 2026 20:21:03
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 29Th May 2026
Brooks Labs board approved Q4 FY26 cons. net profit of ₹152.30 lakhs and FY26 cons. net profit of ₹2,458.35 lakhs. The company also appointed Mr. Prashant Rathi as CEO and reaffirmed its exclusive focus on pharmaceutical operations.
May 29 2026 20:08:27
Read More